Neurophet AQUA AD Plus
Overview
Neurophet AQUA AD Plus is an AI-based software solution designed to support the clinical evaluation of Alzheimer’s disease. It analyzes brain MRI and PET images to automatically identify and quantify lesions, brain structures, and atrophy. The software helps clinicians monitor potential treatment-related side effects in patients receiving anti-amyloid therapies and provides quantitative insights to facilitate informed clinical decision-making. It integrates MRI and PET analysis within a single software environment, allowing for comprehensive assessment of Alzheimer’s disease-related imaging data. The tool also supports early diagnosis and staging of Alzheimer’s disease, safe treatment management by detecting microbleeds and assessing treatment-related side effects, and long-term monitoring of disease progression and treatment efficacy.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered brain MRI analysis
- Automated identification and quantification of hypointense lesions (cerebral microbleeds, superficial siderosis)
- Automated identification and quantification of hyperintense lesions (brain edema)
- Quantitative analysis of MRI and PET images
- Automated labeling and visualization of brain structures
- Volumetric quantification of brain structures and lesions
- Standardized Uptake Value Ratio (SUVR) analysis for PET imaging
- Comparison with normative reference data
- Report generation
- Multi-time-point analysis
Use Cases
- Monitoring potential treatment-related side effects in Alzheimer's patients receiving anti-amyloid therapies
- Supporting imaging-based clinical decision-making in Alzheimer's disease
- Early diagnosis and staging of Alzheimer's disease
- Assessing patient eligibility for Alzheimer's disease treatments
- Evaluating treatment outcomes after administration of Alzheimer's therapies
- Long-term monitoring of disease progression and treatment efficacy
Details
| Category | Neurology AI, Radiology & Imaging AI |
| Pricing | Unknown |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Neurology, Nuclear Medicine, Radiology |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2026-01-29 | K252496 510(k) | Neurophet AQUA AD Plus |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Neurophet AQUA AD Plus
Videos
Product demos, reviews, and walkthroughs for Neurophet AQUA AD Plus.
No FAQs available yet for this tool.






